BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang CJ, Shi SB, Tian J, Xu J, Niu ZX. lncRNA MALAT1, HOTTIP and PVT1 as predictors for predicting the efficacy of GEM based chemotherapy in first-line treatment of pancreatic cancer patients. Oncotarget 2017;8:95108-15. [PMID: 29221115 DOI: 10.18632/oncotarget.19345] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Gong R, Jiang Y. Non-coding RNAs in Pancreatic Ductal Adenocarcinoma. Front Oncol. 2020;10:309. [PMID: 32257946 DOI: 10.3389/fonc.2020.00309] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
2 El-Ashmawy NE, Al-Ashmawy GM, Hamouda SM. Long non-coding RNA FAM83H-AS1 as an emerging marker for diagnosis, prognosis and therapeutic targeting of cancer. Cell Biochem Funct 2021;39:350-6. [PMID: 33159470 DOI: 10.1002/cbf.3601] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Li Y, Al Hallak MN, Philip PA, Azmi AS, Mohammad RM. Non-Coding RNAs in Pancreatic Cancer Diagnostics and Therapy: Focus on lncRNAs, circRNAs, and piRNAs. Cancers (Basel) 2021;13:4161. [PMID: 34439315 DOI: 10.3390/cancers13164161] [Reference Citation Analysis]
4 Lei L, Chen J, Huang J, Lu J, Pei S, Ding S, Kang L, Xiao R, Zeng Q. Functions and regulatory mechanisms of metastasis‐associated lung adenocarcinoma transcript 1. J Cell Physiol 2019;234:134-51. [DOI: 10.1002/jcp.26759] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 5.5] [Reference Citation Analysis]
5 Xie W, Chu M, Song G, Zuo Z, Han Z, Chen C, Li Y, Wang ZW. Emerging roles of long noncoding RNAs in chemoresistance of pancreatic cancer. Semin Cancer Biol 2020:S1044-579X(20)30222-4. [PMID: 33207266 DOI: 10.1016/j.semcancer.2020.11.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
6 Melendez-Zajgla J, Maldonado V. The Role of lncRNAs in the Stem Phenotype of Pancreatic Ductal Adenocarcinoma. Int J Mol Sci 2021;22:6374. [PMID: 34203589 DOI: 10.3390/ijms22126374] [Reference Citation Analysis]
7 Peng F, Shi X, Meng Y, Dong B, Xu G, Hou T, Shi Y, Liu T. Long non-coding RNA HOTTIP is upregulated in renal cell carcinoma and regulates cell growth and apoptosis by epigenetically silencing of LATS2. Biomed Pharmacother 2018;105:1133-40. [PMID: 30021349 DOI: 10.1016/j.biopha.2018.06.081] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
8 van der Sijde F, Vietsch EE, Mustafa DAM, Besselink MG, Groot Koerkamp B, van Eijck CHJ. Circulating Biomarkers for Prediction of Objective Response to Chemotherapy in Pancreatic Cancer Patients. Cancers (Basel) 2019;11:E93. [PMID: 30650521 DOI: 10.3390/cancers11010093] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
9 Sharma GG, Okada Y, Von Hoff D, Goel A. Non-coding RNA biomarkers in pancreatic ductal adenocarcinoma. Semin Cancer Biol 2020:S1044-579X(20)30204-2. [PMID: 33049362 DOI: 10.1016/j.semcancer.2020.10.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
10 Mao Z, Wu Y, Zhou J, Xing C. Salinomycin reduces epithelial-mesenchymal transition-mediated multidrug resistance by modifying long noncoding RNA HOTTIP expression in gastric cancer cells. Anticancer Drugs 2019;30:892-9. [PMID: 30882398 DOI: 10.1097/CAD.0000000000000786] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
11 Ramya Devi KT, Karthik D, Mahendran T, Jaganathan MK, Hemdev SP. Long noncoding RNAs: role and contribution in pancreatic cancer. Transcription 2021;12:12-27. [PMID: 34036896 DOI: 10.1080/21541264.2021.1922071] [Reference Citation Analysis]
12 Liu YF, Luo D, Li X, Li ZQ, Yu X, Zhu HW. PVT1 Knockdown Inhibits Autophagy and Improves Gemcitabine Sensitivity by Regulating the MiR-143/HIF-1α/VMP1 Axis in Pancreatic Cancer. Pancreas 2021;50:227-34. [PMID: 33565800 DOI: 10.1097/MPA.0000000000001747] [Reference Citation Analysis]
13 Barwal TS, Sharma U, Rana MK, Bazala S, Singh I, Murmu M, Kapoor HS, Thakur S, Jain M, Jain A. A diagnostic and prognostic value of blood-based circulating long non-coding RNAs in Thyroid, Pancreatic and Ovarian Cancer. Crit Rev Oncol Hematol 2022;:103598. [PMID: 35033662 DOI: 10.1016/j.critrevonc.2022.103598] [Reference Citation Analysis]
14 Amodio N, Raimondi L, Juli G, Stamato MA, Caracciolo D, Tagliaferri P, Tassone P. MALAT1: a druggable long non-coding RNA for targeted anti-cancer approaches. J Hematol Oncol 2018;11:63. [PMID: 29739426 DOI: 10.1186/s13045-018-0606-4] [Cited by in Crossref: 123] [Cited by in F6Publishing: 119] [Article Influence: 30.8] [Reference Citation Analysis]
15 Mortoglou M, Tabin ZK, Arisan ED, Kocher HM, Uysal-Onganer P. Non-coding RNAs in pancreatic ductal adenocarcinoma: New approaches for better diagnosis and therapy. Transl Oncol 2021;14:101090. [PMID: 33831655 DOI: 10.1016/j.tranon.2021.101090] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Lou S, Xu J, Wang B, Li S, Ren J, Hu Z, Xu B, Luo F. Downregulation of lncRNA AFAP1-AS1 by oridonin inhibits the epithelial-to-mesenchymal transition and proliferation of pancreatic cancer cells. Acta Biochim Biophys Sin (Shanghai) 2019;51:814-25. [PMID: 31314060 DOI: 10.1093/abbs/gmz071] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
17 Ghafouri-Fard S, Ashrafi Hafez A, Taheri M. Metastasis Associated Lung Adenocarcinoma Transcript 1: An update on expression pattern and functions in carcinogenesis. Exp Mol Pathol 2020;112:104330. [PMID: 31712117 DOI: 10.1016/j.yexmp.2019.104330] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
18 Wang Y, Zhou L, Lu J, Jiang B, Liu C, Guo J, Xiao GG. Research progress on long non-coding RNAs and their roles as potential biomarkers for diagnosis and prognosis in pancreatic cancer. Cancer Cell Int. 2020;20:457. [PMID: 32973402 DOI: 10.1186/s12935-020-01550-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
19 Shao G, Zhao Z, Zhao W, Hu G, Zhang L, Li W, Xing C, Zhang X. Long non-coding RNA MALAT1 activates autophagy and promotes cell proliferation by downregulating microRNA-204 expression in gastric cancer. Oncol Lett 2020;19:805-12. [PMID: 31897197 DOI: 10.3892/ol.2019.11184] [Cited by in Crossref: 5] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
20 Wang H, Wang F, Ouyang W, Jiang X, Li W. MALAT1 knockdown inhibits hypopharyngeal squamous cell carcinoma malignancy by targeting microRNA-194. Oncol Lett 2020;20:173-82. [PMID: 32565945 DOI: 10.3892/ol.2020.11551] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]